Quantity size:
0.2ml
Concentration:
1mg/ml 离子钙接头蛋白抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Allograft Inflammatory Factor-1 (AIF1)or ionized calcium-binding adaptor molecule 1 (Iba1) is expressed selectively in microglia/macrophages and is a Ca2+-binding peptide produced by activated monocytes and microglial cells. It has been suggested that AIF1 expression is associated 离子钙接头蛋白抗体with chronic inflammatory processes. AIF1 is expressed by activated monocytes and might participate in a variety of pathogenic processes in the mammalian brain and in chronic transplant rejection. It has been shown to be expressed early and persistently in chronically rejecting cardiac allografts but not in cardiac syngrafts and host hearts.
离子钙接头蛋白抗体Also known as:
AIF 1; AIF1; AIF1 protein; IBa1; iba-1; IBa 1; allograft inflammatory factor 1; Allograft inflammatory factor 1 splice variant G; balloon angioplasty responsive transcription; BART 1; G1; G1 putative splice variant of allograft inflamatory factor 1; IBA 1; IBA1; interferon gamma responsive transcript; Ionized calcium binding adapter molecule 1; 离子钙接头蛋白抗体ionized calcium-binding adapter molecule; IRT 1; IRT1; Microglia response factor; MRF1; Protein G1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Iba1 (11.
●
离子钙接头蛋白抗体Predicted Molecular Weight: 16kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl028Mu01红细胞生成素(EPO)多克隆抗体Polyclonal Antibody to Erythropoietin (EPO)
kl028Ra01红细胞生成素(EPO)多克隆抗体Polyclonal Antibody to Erythropoietin (EPO)
kl217Hu01透明质酸酶(HAase)多克隆抗体Polyclonal Antibody to Hyaluronidase (HAase)
kl217Mu01透明质酸酶(HAase)多克隆抗体Polyclonal Antibody to Hyaluronidase (HAase)
kl217Ra01透明质酸酶(HAase)多克隆抗体Polyclonal Antibody to Hyaluronidase (HAase)
kl632Hu01胃蛋白酶(PP)多克隆抗体Polyclonal Antibody to Pepsin (PP)
kl632Po01胃蛋白酶(PP)多克隆抗体Polyclonal Antibody to Pepsin (PP)
kl769Hu01肝脂酶(LIPC)多克隆抗体Polyclonal Antibody to Likle, Heklic (LIPC)
kl769Mu01肝脂酶(LIPC)多克隆抗体Polyclonal Antibody to Likle, Heklic (LIPC)
kl769Ra01肝脂酶(LIPC)多克隆抗体Polyclonal Antibody to Likle, Heklic (LIPC)
kl769Po01肝脂酶(LIPC)多克隆抗体Polyclonal Antibody to Likle, Heklic (LIPC)
kl226Hu01胃脂酶(LIPF)多克隆抗体Polyclonal Antibody to Likle, Gastric (LIPF)
kl226Mu01胃脂酶(LIPF)多克隆抗体Polyclonal Antibody to Likle, Gastric (LIPF)
kl226Ra01胃脂酶(LIPF)多克隆抗体Polyclonal Antibody to Likle, Gastric (LIPF)
kl226Po01胃脂酶(LIPF)多克隆抗体Polyclonal Antibody to Likle, Gastric (LIPF)
kl469Hu01内皮脂肪酶(LIPG)多克隆抗体Polyclonal Antibody to Likle, Endothelial (LIPG)
kl469Mu01内皮脂肪酶(LIPG)多克隆抗体Polyclonal Antibody to Likle, Endothelial (LIPG)
kl469Ra01内皮脂肪酶(LIPG)多克隆抗体Polyclonal Antibody to Likle, Endothelial (LIPG)
kl176Hu01脂肪酶I(LIPI)多克隆抗体Polyclonal Antibody to Likle I (LIPI)
kl176Mu01脂肪酶I(LIPI)多克隆抗体Polyclonal Antibody to Likle I (LIPI)
kl176Ra01脂肪酶I(LIPI)多克隆抗体Polyclonal Antibody to Likle I (LIPI)
kl175Hu01脂肪酶H(LIPH)多克隆抗体Polyclonal Antibody to Likle H (LIPH)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话